Legend Biotech interim CEO Alan Bash files initial beneficial ownership statement
LEGN•Initial Form 3 disclosure
Legend Biotech interim CEO Alan Bash filed an initial Form 3 disclosing 30,234 ordinary shares, including 13,092 RSUs vesting Dec. 20, 2026.
